• linkedin
  • Increase Font
  • Sharebar

    Global generics drug market to grow 10% annually

    The global generic drugs market is expected to grow at a compounded annual growth rate of 10.53% from 2016 through 2020, according to a new report.

    In fact, according to ReportsnReports.com, the global generic drugs market will benefit from the patent expiry of drugs worth $150 billion by 2020.

    “With many pharmaceutical drugs set to lose their patents during the forecast period, the competition in the generic market is expected to increase,” the report said. “Branded drugs with sales of up to $135 billion expired by the end of 2015, offering pharmaceutical companies opportunities to capitalize on this market.”

    Editor’s Pick: How Walmart plans to save on generics

    In 2020

    In 2020, the largest volume of medications will be generics and non-original branded products, primarily in emerging pharmacy markets such as China, Brazil, India, Russia, Chile, Columbia, Indonesia, Mexico, Pakistan, and Turkey, according to the IMS Institute for Healthcare Informatics. These drug products are often available at lower costs than original branded products and contribute significantly to increased access to medications in these countries.

    In addition, more than 90% of U.S. medications will be dispensed as generics by 2020, according to IMS Institute.

    “Generic medicines will continue to provide the vast majority of the prescription drug usage in the United States, rising from 88% to 91% to 92% of all prescriptions dispensed by 2020,” stated IMS Institute’s Global Medicines Use in 2020: Outlook and Implications report.

    The expirations of branded drug patents have had a signficant impact on the growth of generics. In fact, according to IMS Institute, the increase in U.S. drug spending to $310 billion in 2015 was fueled by new brands and protected brand price increases, offset by the impact of patent expiries.

    “The greater use of generics and a small increase in demand for branded drugs contributed to the spending growth,” the organization said.

    Christine Blank
    Contributing Editor Christine Blank is a freelance writer based in Florida.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available